Board of Pharmacy public meetings in 2021
4 substantive meetings from 2021, with official agendas or minutes and plain-English summaries.
Board of Pharmacy
The Louisiana Board of Pharmacy will meet to consider regulatory proposals on raw marijuana products and fees, a resolution opposing recreational marijuana legalization, and the proposed budget for FY 2022-2023. The board will also hear a presentation from Wal-Mart on return-to-stock processes and address multiple enforcement actions and policy updates.
- Consideration of Regulatory Proposal 2021-D on raw marijuana products
- Consideration of Regulatory Proposal 2021-G on fees
- Consideration of proposed budget for fiscal year 2022-2023
- Consideration of resolution to oppose recreational marijuana legalization in Louisiana
- Presentation from Wal-Mart on return-to-stock process in central fill pharmacies
The Board elected Marty R. McKay as President and approved the proposed budget for Fiscal Year 2022-2023. Members authorized a pilot project for Wal-Mart's return-to-stock process and approved new regulations regarding raw marijuana products and program fees. The Board also voted to oppose the legalization of recreational marijuana in Louisiana.
- Elected Marty R. McKay as President (unanimous)
- Approved Proposed Budget for Fiscal Year 2022-2023 (unanimous)
- Approved Regulatory Proposal 2021-D regarding Raw Marijuana Products (unanimous)
- Approved Regulatory Proposal 2021-G regarding program fees (unanimous)
- Authorized Wal-Mart return-to-stock pilot project through Dec 31, 2022 (unanimous)
- Approved resolution opposing legalization of recreational marijuana (unanimous)
- Fined Enclara Pharmacia, Inc. $5,000 via voluntary consent agreement (unanimous)
- Approved 14 PMP reporting waivers for various pharmacies (unanimous)
Board of Pharmacy
The Louisiana Board of Pharmacy will vote on proposed voluntary consent agreements for several pharmacies and individuals, including three Walgreen locations. The board will also consider regulatory proposals on hemp facilities and medication administration, as well as a request to relocate a pharmacy permit for RxONE Livingston. Other items include committee reports, budget amendments, and updates on the prescription monitoring program.
- Proposed voluntary consent agreements for Walgreen Pharmacy #11830 (Marksville), #06028 (Baton Rouge), #02012 (Alexandria), and Archway Apothecary (Covington)
- Consideration of Regulatory Project 2020-10 on CDS license for hemp facility and Regulatory Proposal 2021-E on hemp facility
- Consideration of Regulatory Proposal 2021-F on medication administration
- Reconsideration of previous decision regarding the 10th marijuana pharmacy permit
- Request for exception to relocation rules for RxONE Livingston (Walker, LA)
The Board appointed Joe Fontenot to succeed the retiring executive director in June 2022. The Board also approved a budget amendment, updated several pharmacy regulations, and issued multiple disciplinary fines and license suspensions.
- Selected Joe Fontenot as executive director-designate (unanimous)
- Deferred awarding the 10th marijuana pharmacy permit until after January 1, 2023 (unanimous)
- Approved FY 2020-2021 Final Report subject to legislative audit (unanimous)
- Adopted Draft #2 of Proposed Budget Amendment No. 1 for FY 2021-2022 (unanimous)
- Granted relocation exception for RxONE Livingston from Walker to Gonzales, LA (unanimous)
- Granted prescription file transfer exception for Lil Daves Pharmacy from Donaldsonville to Plaquemine, LA (unanimous)
- Approved Regulatory Proposal 2021-F to eliminate medication administration registration credential (unanimous)
- Suspended certificates for Danielle Kristen Ducote, Jenna Marie Graves, Brittney Nicole Artison, and Karla Michelle Abbitt with $500 fines each (unanimous)
Board of Pharmacy
The Board is considering several voluntary consent agreements regarding pharmacy and pharmacist conduct. The meeting also includes reviews of regulatory projects for hemp facilities and the renewal of multiple professional service contracts.
- Proposed voluntary consent agreements for DMD Ventures, LLC d/b/a NOLA Discount Pharmacy #2
- Review of CDS License for Hemp Facility regulatory project
- Annual renewal of contracts for professional legal, accounting, and information services
- Consideration of pharmacy technician training program at Louisiana Delta Community College
- Implementation plan for the issuance of the 10th marijuana pharmacy permit
The Board approved an implementation plan to issue a tenth marijuana pharmacy permit in Region 9. It also ratified several professional service contracts, updated policy manuals, and issued disciplinary actions against various licensees.
- Approved implementation plan for 10th marijuana pharmacy permit in Region 9
- Approved $700,000 agreement for PMP Gateway and NarxCare integration
- Approved $200,000 agreement with Appriss, Inc. for prescription monitoring program
- Issued $10,000 fine and Letter of Reprimand to Melior, Inc. d/b/a Lil Daves
- Issued $10,000 fine and Letter of Reprimand to David Keith Chauvin, Jr.
- Revoked registration of Joshua Shabazz Higgins
- Approved $100,000 legal services contract for Celia R. Cangelosi
- Approved $50,000 legal services contract for Shows, Cali & Walsh, LLP
Board of Pharmacy
The Louisiana Board of Pharmacy will meet via videoconference on February 24, 2021, due to the COVID-19 public health emergency. The agenda includes committee reports on finance, violations, and regulation revision, with consideration of multiple proposed voluntary consent agreements for licensees. The board will also consider regulatory and legislative proposals on pharmacy benefit managers, collaborative practice, limited prescriptive authority, and COVID-19 guidance.
- Consideration of comments from public hearing on Regulatory Project 2020-4 ~ Pharmacy Benefit Managers
- Consideration of Regulatory Proposal 2021-A ~ Collaborative Practice
- Consideration of Legislative Proposal 2021-D ~ Limited Prescriptive Authority
- Consideration of multiple voluntary consent agreements (e.g., Case No. 20-0349 ~ Melior, Inc. d/b/a Lil Daves [Plaquemine, LA])
- Consideration of Proposed PPM.I.D.28 ~ COVID-19 Public Health Emergency: Guidance for Licensees
The Board approved several legislative proposals regarding collaborative practice, limited prescriptive authority, and renewal fees. It also ratified numerous voluntary consent agreements involving fines and license restrictions for pharmacists and pharmacies. Additionally, the Board updated interim COVID-19 policies and approved a new pharmacy technician training program.
- Approved Legislative Proposal 2021-C for Collaborative Practice
- Approved Legislative Proposal 2021-D for Limited Prescriptive Authority
- Approved Legislative Proposal 2021-B to revise renewal fees
- Approved Legislative Proposal 2021-A for CDS Schedule Update
- Approved Legislative Proposal 2021-E for Louisiana Medicaid PMP audit trail access
- Approved 19 voluntary consent agreements including fines for Central Drug Store, Inc. ($25,000) and Sofie, Co. ($10,000)
- Approved pharmacy technician training program at Sullivan College of Pharmacy & Health Sciences
- Approved proposal from Covalent Logic to update the Board's website